Exact Sciences Corp
EXASDelisted- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001124140
Exact Sciences Corp was delisted in 2026; its insiders filed their last Form 4 on Mar 23, 2026; 712 institutions reported holding it in 13F filings for Q4 2025, worth $17.9B in total; superinvestors Soros Fund Management and ARK Invest held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 712
- Q4 2025, +156 vs. previous quarter
- 13F value
- $17.9B
- Reported value at the end of Q4 2025
- Superinvestors holding
- 2
- At the end of Q4 2025
Superinvestors holding EXAS, Q4 2025
2 superinvestors report holding Exact Sciences Corp on Form 13F. Percentages are the stock's share of each portfolio.
Soros Fund Management
George Soros
1.2%
Exact Sciences Corp's share of the portfolio
- Shares
- 864,009
- Value
- $87.7M
Latest insider trades
Open-market purchases and sales by Exact Sciences Corp insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 21, 2025 (view filing) | Nov 19 | 2 days | Orville Jacob AEVP, GM, Screening | SSale | −5.00K | $75.00 | −$375.0K | −17.7%23.2K after | 10b5-1 |
| Nov 21, 2025 (view filing) | Nov 19 | 2 days | Herriott JamesSVP, General Counsel & Sec | SSale | −1.00K | $70.00 | −$70.0K | −7.9%11.6K after | 10b5-1 |
| Nov 6, 2025 (view filing) | Nov 4 | 2 days | Herriott JamesSVP, General Counsel & Sec | SSale | −1.50K | $70.08 | −$105.1K | −10.6%12.6K after | 10b5-1 |
| Nov 6, 2025 (view filing) | Nov 4 | 2 days | Baranick BrianEVP, GM, Precision Oncology | SSale | −2.86K | $70.08 | −$200.3K | −11.3%22.4K after | 10b5-1 |
| Oct 27, 2025 (view filing) | Oct 24 | 3 days | Zanotti Katherine SDirector | SSale | −12.0K | $65.00 | −$780.0K | −16.5%60.8K after | 10b5-1 |
| Oct 10, 2025 (view filing) | Oct 9 | 1 day | Herriott JamesSVP, General Counsel & Sec | SSale | −1.50K | $60.00 | −$90.0K | −9.6%14.1K after | 10b5-1 |
| Oct 10, 2025 (view filing) | Oct 9 | 1 day | Doyle James EdwardDirector | SSale | −2.00K | $60.00 | −$120.0K | −3.3%58.0K after | 10b5-1 |
| Aug 14, 2025 (view filing) | Aug 13 | 1 day | Doyle James EdwardDirector | SSale | −1.49K | $42.02 | −$62.4K | −2.4%60.0K after | 10b5-1 |
| Jun 16, 2025 (view filing) | Jun 13 | 3 days | Zanotti Katherine SDirector | SSale | −3.21K | $53.20 | −$170.6K | −4.2%72.8K after | 10b5-1 |
| Nov 13, 2024 (view filing) | Nov 13 | Same day | Conroy Kevin TPresident and CEO | PPurchase | +19.5K | $51.35 | +$1.00M | +1.8%1.07M after |
Top 10 13F holders, Q4 2025
The largest institutional positions in Exact Sciences Corp at the end of Q4 2025; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 17,415,415 | $1.77B | 0.03% | −393,062−2.2% | Reduced |
| BlackRock, Inc. | 15,134,118 | $1.54B | 0.03% | +4,571,957+43.3% | Added |
| HBK Investments L P | 7,646,637 | $776.6M | 8.41% | +7,646,637 | New |
| Pentwater Capital Management LP | 7,250,000 | $736.3M | 5.33% | +7,250,000 | New |
| Farallon Capital Management, L.L.C. | 6,405,000 | $650.5M | 3.38% | +6,405,000 | New |
| Davidson Kempner Capital Management LP | 4,230,749 | $429.7M | 6.30% | +4,230,749 | New |
| State Street Corp | 4,183,039 | $424.8M | 0.01% | −1,012,242−19.5% | Reduced |
| Balyasny Asset Management LLC | 4,089,977 | $415.4M | 0.78% | +3,242,412+382.6% | Added |
| Millennium Management LLC | 3,441,516 | $349.5M | 0.25% | +1,224,082+55.2% | Added |
| Norges Bank | 3,430,733 | $348.4M | 0.04% | +3,430,733 | New |